<DOC>
	<DOCNO>NCT02320539</DOCNO>
	<brief_summary>The purpose study validate result related trial ( NCT01791257 ) compare profile microRNA blood patient suffer subarachnoid hemorrhage without systemic complication .</brief_summary>
	<brief_title>MicroRNA Diagnostics Subarachnoid Hemorrhage 2</brief_title>
	<detailed_description>In study patient suffer aneurysmal subarachnoid hemorrhage ( SAH ) would like validate former result CSF study microRNA profile investigate pathophysiological mechanism lead systemic complication cardiac dysfunction , acute lung injury ( ALI ) systemic inflammatory response syndrome ( SIRS ) . We accomplish analyze profile microRNA expression blood cerebrospinal fluid SAH patient . Validation : As early study wish compare expression 20 specific microRNA 12 patient develop DCI ( group 1 ) 12 patient without DCI ( group 2 ) cerebrospinal fluid drawn day 5 ictus . In addition , patient establish invasive neuromonitoring include microdialysis study change certain microRNAs . DCI define Vergouwen et al Stroke 2010 ; 41 ( 10 ) :2391-2395 : `` The occurrence focal neurological impairment ( hemiparesis , aphasia , apraxia , hemianopia , neglect ) , decrease least 2 point Glasgow Coma Scale ( either total score one individual component [ eye , motor either side , verbal ] ) . This last least 1 hour , apparent immediately aneurysm occlusion , attribute cause mean clinical assessment , CT MRI scan brain , appropriate laboratory study . '' Systemic complication : Furthermore , wish compare expression 754 specific microRNA blood draw day 3 ictus patient ALI ( describe Kahn et al , Crit Care Med . 2006 ; 34 : 196-202 ) patient without ALI . Of least 36 patient expect include 12 statistically develop ALI accord referred definition . Additionally , wish compare expression 754 specific microRNA 12 patient develop DCI ( group 1 ) 12 patient without DCI ( group 2 ) blood draw day 3 ictus . Moreover , wish compare expression 754 specific microRNA blood 36 patient ( group 1-3 ) healthy control . The specific microRNAs interest expression blood patient systemic complication analyze daily investigate dynamic change expression compare clinical course .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>Inclusion Criteria Group 13 : Uncertainty &lt; 24 time time ictus Inclusion Criteria Group 12 : Patients admit Neurointensive Department Rigshospitalet aneurysmal SAH treat external ventricular drain . Inclusion Criteria Group 3 : Patients admit Neurointensive Department Rigshospitalet aneurysmal SAH treat without external ventricular drain . Exclusion Criteria Group 13 : Transfer hospital within 5 day admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>MicroRNA</keyword>
	<keyword>Cerebrospinal fluid</keyword>
</DOC>